Abstract
Drug pricing is one of the key levers that determine the profitability of a
drug company. Premium pricing of a new drug helps cover the high cost of
innovation and helps run a profitable enterprise. But the recent onslaught of
generics, as well as shrinking government and corporate healthcare budgets, is
threatening the time-tested models, leading to higher pricing pressures for
pharmaceutical and biotech companies in the coming years. In this environment,
executives in these companies and the consultants who service them need better
information to make the most profitable decisions.
Kalorama Information' s A Guide to Drug Pricing and Reimbursement provides
considerable detail on the this all-important area of pharmaceutical marketing
strategy. The guide describes pricing strategies for specific results,
including:
- Gaining Market Share
- Defending Market Share
- Enhancing Brand Loyalty
- Gaining New Customers
- Improving Margins
- Utilizing Capacity
The result of exhaustive research into recent pricing trends as well as
interviews with top pharmaceutical executives, the Guide provides executives
in pricing decision capacities with critical information needed to arrive at
the most effective strategy:
- Useful statistics detailing the Overall Pharmaceutical Pricing
Environment, including Healthcare Expenditures, Pharmaceutical
Expenditures and Drug Prices in Select Countries as well as Biopharmaceutical
R&D Expenditures
- Updated Medicare Reimbursement Information for Parts A,B,C and D
- The Development phases in which it is most important to consider
pricing
- Overview of U.S. Pharmaceutical Market (including Healthcare
Spending, Promotional Spending, Average Co Payments, Generic Drug Trends,
Single Source Brand Vs. AWP and more.)
- Pricing Strategies for the European Market
- Japanese Market Pricing and Reimbursement Strategies.
Drug pricing and reimbursement also differs widely across the globe due to the
huge disparity in economic situations of various countries, and this global
report addresses the pricing environments in:
Pricing and reimbursement will remain one of the most talked about industry
issues going into the next decade. This report aims to provide a holistic view
on pricing and reimbursement across the globe. This report enables executives
to make proactive decisions and to craft their responses to the changing
dynamics of the market.
| 
View Cart
